{
    "root": "35a7289a-d7c1-32cf-e063-6394a90aeebd",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Aripiprazole",
    "value": "20250521",
    "ingredients": [
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "HYDROXYPROPYL CELLULOSE (1600000 WAMW)",
            "code": "RFW2ET671P"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "ARIPIPRAZOLE",
            "code": "82VFR53I78"
        }
    ],
    "indications": "aripiprazole oral tablets , indicated treatment : schizophrenia acute treatment manic mixed episodes associated bipolar disorder adjunctive treatment major depressive disorder irritability associated autistic disorder treatment tourette ’ disorder",
    "contraindications": "initial dose recommended dose maximum dose schizophrenia – adults ( 2.1 ) 10 15 mg/day 10 15 mg/day 30 mg/day schizophrenia – adolescents ( 2.1 ) 2 mg/day 10 mg/day 30 mg/day bipolar mania – adults : monotherapy ( 2.2 ) 15 mg/day 15 mg/day 30 mg/day bipolar mania – adults : adjunct lithium valproate ( 2.2 ) 10 15 mg/day 15 mg/day 30 mg/day bipolar mania – pediatric patients : monotherapy adjunct lithium valproate ( 2.2 ) 2 mg/day 10 mg/day 30 mg/day major depressive disorder – adults : adjunct antidepressants ( 2.3 ) 2 5 mg/day 5 10 mg/day 15 mg/day irritability associated autistic disorder – pediatric patients ( 2.4 ) 2 mg/day 5 10 mg/day 15 mg/day tourette ’ disorder – ( 2.5 ) patients < 50 kg 2 mg/day 5 mg/day 10 mg/day patients ≥ 50 kg 2 mg/day 10 mg/day 20 mg/day • oral formulations : administer daily without regard meals ( 2 ) • known cyp2d6 poor metabolizers : half usual dose ( 2.7 )",
    "warningsAndPrecautions": "aripiprazole tablets , usp markings one side available 20 mg , white off-white round , “ ari ” “ 20 ” ndc : 70518-2806-00 ndc : 70518-2806-01 ndc : 70518-2806-02 ndc : 70518-2806-03 packaging : 30 1 box packaging : 1 1 pouch packaging : 30 1 blister pack packaging : 30 1 blister pack store 25°c ( 77°f ) ; excursions permitted 15°c 30°c ( 59°f 86°f ) [ usp controlled room temperature ] . repackaged distributed : remedy repack , inc. 625 kolter dr. suite # 4 indiana , pa 1-724-465-8762",
    "adverseReactions": "aripiprazole tablets contraindicated patients history hypersensitivity reaction aripiprazole . ranged pruritus/urticaria anaphylaxis [ ( 6.2 ) ] .",
    "indications_original": "Aripiprazole Oral Tablets, are indicated for the treatment of:\n                  \n                  \n                     Schizophrenia\n  \n    \n                     \n                     Acute Treatment of Manic and Mixed Episodes associated with Bipolar I Disorder\n  \n    \n                     \n                     Adjunctive Treatment of Major Depressive Disorder\n  \n    \n                     \n                     Irritability Associated with Autistic Disorder\n  \n     \n                     \n                     Treatment of Tourette’s Disorder",
    "contraindications_original": "Initial Dose Recommended Dose Maximum Dose Schizophrenia – adults ( 2.1 ) 10 to 15 mg/day 10 to 15 mg/day 30 mg/day Schizophrenia – adolescents ( 2.1 ) 2 mg/day 10 mg/day 30 mg/day Bipolar mania – adults: monotherapy ( 2.2 ) 15 mg/day 15 mg/day 30 mg/day Bipolar mania – adults: adjunct to lithium or valproate ( 2.2 ) 10 to 15 mg/day 15 mg/day 30 mg/day Bipolar mania – pediatric patients: monotherapy or as an adjunct to lithium or valproate ( 2.2 ) 2 mg/day 10 mg/day 30 mg/day Major Depressive Disorder – adults: adjunct  to antidepressants ( 2.3 ) 2 to 5 mg/day 5 to 10 mg/day 15 mg/day Irritability associated with autistic disorder – pediatric patients ( 2.4 ) 2 mg/day 5 to 10 mg/day 15 mg/day Tourette’s disorder – ( 2.5 ) Patients < 50 kg 2 mg/day 5 mg/day 10 mg/day Patients ≥ 50 kg 2 mg/day 10 mg/day 20 mg/day • Oral formulations: Administer once daily without regard to meals ( 2 ) • Known CYP2D6 poor metabolizers: Half of the usual dose ( 2.7 )",
    "warningsAndPrecautions_original": "Aripiprazole Tablets, USP have markings on one side and are available\n                  20 mg, White to off-white round, “ARI”and “20”\n                  NDC: 70518-2806-00\n                  NDC: 70518-2806-01\n                  NDC: 70518-2806-02\n                  NDC: 70518-2806-03\n                  PACKAGING: 30 in 1 BOX\n                  PACKAGING: 1 in 1 POUCH\n                  PACKAGING: 30 in 1 BLISTER PACK\n                  PACKAGING: 30 in 1 BLISTER PACK\n                  \n                  Store at 25°C (77°F); excursions permitted between 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].\n                  Repackaged and Distributed By:\n                  Remedy Repack, Inc.\n                  625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762",
    "adverseReactions_original": "Aripiprazole Tablets is contraindicated in patients with a history of a hypersensitivity reaction to aripiprazole. Reactions have ranged from pruritus/urticaria to anaphylaxis\n \n  [see Adverse Reactions (\n  \n   6.2)]."
}